Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K K Uberla

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
MMW, Munchener Medizinische Wochenschrift|June 13, 1980
[Epidiology today]K K Uberla
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1980
[Alternative clinical therapeutic evaluation]K K Uberla
MMW, Munchener Medizinische Wochenschrift|May 7, 1982
[How many patients are needed for a therapeutic trial? Viewpoints of clinical research (author's transl)]K K Uberla
MMW, Munchener Medizinische Wochenschrift|September 3, 1982
[Safety and risk in the drug field: fiction and reality]K K Uberla
International Journal of Epidemiology|January 1, 1990
Boundaries of perception and knowledge for risk assessment in epidemiologyK K Uberla
MMW, Munchener Medizinische Wochenschrift|April 24, 1981
[Ethical questions in trials in humans as seen by the biometrician (author's transl)]K K Uberla
Controlled Clinical Trials|May 1, 1981
Randomized clinical trials: why not?K K Uberla
Der Internist|March 1, 1981
[Statistical instruments in medical prognosis]K K Uberla, M A Schreiber
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1980
[Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo]H K Breddin, K K Uberla
MMW, Munchener Medizinische Wochenschrift|December 21, 1979
[Assured quality--a challenge in medicine]H K Selbmann, K K Uberla
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
MMW, Munchener Medizinische Wochenschrift|June 13, 1980
[Epidiology today]K K Uberla
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1980
[Alternative clinical therapeutic evaluation]K K Uberla
MMW, Munchener Medizinische Wochenschrift|May 7, 1982
[How many patients are needed for a therapeutic trial? Viewpoints of clinical research (author's transl)]K K Uberla
MMW, Munchener Medizinische Wochenschrift|September 3, 1982
[Safety and risk in the drug field: fiction and reality]K K Uberla
International Journal of Epidemiology|January 1, 1990
Boundaries of perception and knowledge for risk assessment in epidemiologyK K Uberla
MMW, Munchener Medizinische Wochenschrift|April 24, 1981
[Ethical questions in trials in humans as seen by the biometrician (author's transl)]K K Uberla
Controlled Clinical Trials|May 1, 1981
Randomized clinical trials: why not?K K Uberla
Der Internist|March 1, 1981
[Statistical instruments in medical prognosis]K K Uberla, M A Schreiber
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1980
[Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo]H K Breddin, K K Uberla
MMW, Munchener Medizinische Wochenschrift|December 21, 1979
[Assured quality--a challenge in medicine]H K Selbmann, K K Uberla
Pageof 2